Protected: Health Policy Academy 2021
There is no excerpt because this is a protected post.
Click on an event to access its materials, such as videos, transcripts, and presentations.
A Year in Review: America’s Fight Against COVID-19
Expert panelists delved into where America stands in public health a year into the COVID-19 pandemic. They discussed how the COVID-19 pandemic has shaped clinical care, state preparedness, and the individual consumer experience and shed light on promising frameworks and infrastructures being built today to protect Americans from a major public health emergency tomorrow.
Why Our Vaccine Deployment is Shy of Target: State Responses to Vaccine Supply
Attendees learned the challenges and opportunities states face in safe and timely vaccine deployment and supply management, plans states are executing to ensure equitable vaccine distribution, and plans states are executing to ensure equitable vaccine distribution along the way.
Building Confidence to Build Immunity: Vaccine Hesitancy and COVID-19
This briefing explored the current state of COVID-19 vaccine deployment efforts, cultural, historical, and political influences that may generate feelings of hesitancy, and how to ensure optimal vaccine uptake in key populations.
A Conversation with Dr. Stephen M. Hahn of the U.S. Food and Drug Administration
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
From Bench to Body: How the U.S. Health Care System Plans to Distribute COVID-19 Vaccines
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
Industry Perspectives on COVID-19 Vaccine Deployment
This discussion focused on measures industry stakeholders have taken for safe COVID-19 vaccine deployment and the immediate steps these stakeholders will take in the first 48 hours after the Emergency Use Authorization was approved.
Post Election Symposium: Day 2
Sessions on Day 2 of the Post Election Symposium included a fireside chat with futurist Ian Morrison and leaders from the ground discussed the long-term vision for rebuilding the health system.
Post Election Symposium: Day 1
Sessions on Day 1 of the Post Election Symposium provided an analysis of the election results and potential impacts for health care and a discussion on the gaps in our health care system that COVID-19 exposed.
Post Election Symposium
November 16-17 | This virtual symposium will gather a range of experts after election day to discuss how the results could influence the health policy agenda in 2021 and beyond.
Serving Low-Income Seniors: Lessons and the Impact of COVID-19
This briefing will overview the complex ecosystem of federal, state, and private programs that coexist to integrate medical, LTSS, and social services for low-income seniors.
Day 3: Co-Designing a Simpler System
Day 3 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will address how we collect and operationalize patient feedback to create patient-centered care at a systems level.
Day 2: Navigating the Current System
Day 2 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will explore successful mechanisms to support patients navigate the current, highly complex health care system and foster independence in decision making.
Day 1: Best Practices for Collecting Patient Feedback
Day 1 of our Voice of the Patient Summit, a program of the 2020 Signature Series, includes an opening keynote presentation and panel focusing on strategies for effective communication and shared decision making from the patient and caregiver perspectives.
Pandemic Flexibilities in Long-Term Care
The COVID-19 pandemic has exposed both new and longstanding needs of long-term care patients. Experts will overview the recent changes, remaining gaps, and benefits and risks to long-term care patients, caregivers, providers, and payers.
Part I Briefing: COVID-19 Vaccine Deployment
This is the final event in Part I of our Signature Series focusing on disruptors and transformers in health care. This briefing explored the manufacturing, distribution, delivery, and coverage approaches that will enable nationwide COVID-19 vaccine uptake.
A Conversation with Dr. Anand Shah of the U.S. Food and Drug Administration
Dr. Anand Shah provided opening remarks and answered questions about the U.S. Food and Drug Administration’s role in the national COVID-19 response.
Confronting the Mental Health Effects of COVID-19 in America
This solutions-focused discussion explored policy interventions at the federal, state, and local levels to advance mental health during the ongoing pandemic.
A Conversation with Dr. Anthony Fauci
During this on-the-record briefing for reporters, Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Disease at the National Institutes of Health provided insight into the status of the COVID-19 pandemic. Dr. Fauci discussed the status of spread of the virus in the United States and highlighted progress toward successful treatments and vaccines.
The Immediate and Lasting Impacts of COVID-19 on Children
This webinar will address the specific threats posed by COVID-19 to children in the short- and long-term and provide policy options that may support children’s physical and mental health.
An Expert Discussion on the Provider Relief Fund
During this webinar, panelists will address key questions such as: How has the relief fund been distributed to date among different health care entities? What is the financial impact of the pandemic for providers and what are the implications for access to health services? And, what factors should policymakers consider as they weigh additional options to support providers?
Keynote: A Conversation on Innovative Research Approaches to Advance Our Understanding and Treatment of COVID-19
Keynote #2 of our Virtual Summit, a program of the 2020 Signature Series, will discuss the role of the National Institutes of Health’s National COVID Cohort Collaborative (N3C) program in fostering robust-data driven clinical research.
Using Data to Disrupt the Spread of COVID-19 and Prevent Future Pandemics
Panel #3 of our Virtual Summit, a program of the 2020 Signature Series, will explore the role of data sharing, interoperability, and health IT in tracking and stemming the spread of COVID-19.
A conversation with Jenny Bryant of PhRMA
Care Delivery Transformation: Integrating Telehealth and Home-Based Care
Panel #2 of our Virtual Summit, a program of the 2020 Signature Series, will focus on care delivery and payment transformations that have been accelerated or emerged as a result of COVID-19 and explore which systemic changes may become permanent, as well as how to rebuild trust in the health care system.
Keynote: Perspectives on Health Equity with Dr. Rashawn Ray and Licy Do Canto
Keynote #1 of our Virtual Summit, a program of the 2020 Signature Series, will explore structural conditions that have lead to health disparities before COVID and during the current pandemic.
The Invisible Backbone: Strengthening Supply Chain and Public Health Infrastructure
Panel #1 of our Virtual Summit, a program of the 2020 Signature Series, will explore interactions between the vaccine development pipeline, medical supply chain, and contact tracing infrastructures currently serving the US, and how policymakers can leverage and improve these foundational systems moving forward.
COVID-19 Webinar Series Session 20 – Tensions, Tradeoffs, and Takeaways: What’s at Stake for America 100 Days into the Pandemic and Where We Go From Here
Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders will examine the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.
COVID-19 Webinar Series Session 19 – Advancing Mental Health During the Pandemic and Beyond
During this webinar, panelists addressed the following learning goals: the short- and long-term impact of COVID-19 on mental health and well being; evidence-based interventions and promising technology to reach people where they are and improve outcomes; and sustainable solutions to address the mental health impact of COVID-19 and advance access to behavioral health services beyond the pandemic.
COVID-19 Webinar Series Session 18 – Health Inequities: Addressing the Disease Burden in Black, Indigenous, and People of Color Communities
During this webinar, speakers examined the following learning goals: the disproportionate impact of COVID-19 on Black, Indigenous, and People of Color communities in the U.S.; the drivers of these disparities; and short- and long-term policy options to advance equity and improve COVID-19 outcomes.
COVID-19 Webinar Series Session 17 – The Role of Medicaid
This webinar will explain the role of Medicaid in the COVID-19 pandemic. Panelists will discuss financing challenges of the Medicaid program—the nation’s health care safety net—as more people become eligible for Medicaid coverage and demand for health services shifts.
COVID-19 Webinar Series Session 16 – The Changing Landscape of Primary Care
During this webinar, panelists discussed the recent evolution of our primary care system and outlined policy levers to bolster our nation’s primary care infrastructure.
COVID-19 Webinar Series Session 15 – The Pharmaceutical Supply Chain
During this webinar, panelists explored the impact of the pandemic on different facets of the drug supply chain and discussed policy options to strengthen the system.
COVID-19 Webinar Series Session 14 – Lessons from Home and Abroad: Implementing a Contact Tracing Strategy
During this webinar, panelists discussed case studies from abroad and best practices as policymakers look to implement a contact tracing strategy in the United States.
COVID-19 Webinar Series Session 13 – Nursing Home Care
During this webinar, panelists discussed policy options to support high quality care for nursing home residents during the COVID-19 pandemic.
COVID-19 Webinar Series Session 12 – From Data to Decisions: Mobilizing a Surveillance Infrastructure
During this webinar, panelists will explore options policymakers can pursue to strengthen our surveillance infrastructure as we move from mitigation to containment of the COVID-19 pandemic.
COVID-19 Webinar Series Session 11 – Rural Health System Response
In this webinar, panelists will discuss the unique challenges that face rural health systems and the strategies they are employing during the emergency response. They will also highlight current or future legislative and administrative policy solutions.
COVID-19 Webinar Series Session 10 – The Science and Policy of Vaccine Development
During this webinar, experts discussed steps necessary to bring vaccines from the lab to the front lines.
COVID-19 Webinar Series Session 9 – Social Isolation and Loneliness
During this webinar, panelists discussed the consequences of social isolation, as well as potential interventions that government leaders, providers, and communities can implement.
COVID-19 Webinar Series Special Issue – Perspectives from the Veterans Health Administration
During this pre-recorded interview, we spoke with Dr. Richard A. Stone, the VHA’s Executive in Charge. He explained the coronavirus response efforts underway at the Department of Veterans Affairs to meet the needs of veterans and fulfill the department’s “Fourth Mission” to support other health systems responding to this crisis.
Coronavirus and Health System Capacity: Prescription Drugs and Vaccines
With mandated lockdowns and social distancing guidelines in effect throughout the country, policymakers and public health professionals aim to identify other effective approaches to contain the spread of COVID-19. During this teleconference, experts will discuss the prescription drug supply chain, the progression of a COVID-19 vaccine, and the related infrastructure needs.
COVID-19 Webinar Series Session 8 – Advancing Prevention and Treatment: A Conversation with Dr. Mark McClellan
During this webinar, Dr. Mark McClellan, former FDA Commissioner and current director of the Duke-Margolis Center for Health Policy, offered strategies to expedite the development and evaluation of medical products to track, treat, and prevent the novel coronavirus.
Coronavirus and Health System Capacity: State Projections
As the coronavirus spreads, health systems across the country are gearing up for an influx of patients. States play a central role in the organization of health care and public health infrastructure, but a range of resources and legislative decisions, as well as different demographics, can lead to divergent outcomes across states.